Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS
      Biotech

      ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS

      March 4, 2024
      MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies
      Biotech

      MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

      March 4, 2024
      Results from the Clinical Trial of Qilu Pharmaceutical’s Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting
      Biotech

      Results from the Clinical Trial of Qilu Pharmaceutical’s Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting

      March 4, 2024
      PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
      Biotech

      PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope

      January 18, 2024
      « 1 … 50 51 52

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2025